{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:18:04Z","timestamp":1791919084488,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008367","name":"Universit\u00e9 Libre de Bruxelles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RFA-2203-39325"],"award-info":[{"award-number":["RFA-2203-39325"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022720","name":"Fondazione Regionale per la Ricerca Biomedica","doi-asserted-by":"publisher","award":["1750327"],"award-info":[{"award-number":["1750327"]}],"id":[{"id":"10.13039\/501100022720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000910","name":"Conrad N. Hilton Foundation","doi-asserted-by":"publisher","award":["17313"],"award-info":[{"award-number":["17313"]}],"id":[{"id":"10.13039\/100000910","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["1677"],"award-info":[{"award-number":["1677"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005042","name":"Cliniques Universitaires Saint-Luc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["P41EB031771"],"award-info":[{"award-number":["P41EB031771"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014805","name":"Roche SpA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017147","name":"International Progressive MS Alliance","doi-asserted-by":"publisher","award":["21NS037"],"award-info":[{"award-number":["21NS037"]}],"id":[{"id":"10.13039\/100017147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["40008331"],"award-info":[{"award-number":["40008331"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS082347"],"award-info":[{"award-number":["R01NS082347"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ebiom.2023.104701","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T16:50:16Z","timestamp":1689007816000},"page":"104701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["B cell depletion therapy does not resolve chronic active multiple sclerosis lesions"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1697-5585","authenticated-orcid":false,"given":"Pietro","family":"Maggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin Vanden","family":"Bulcke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Pedrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Bugli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Sellimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxence","family":"Wynen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"St\u00f6lting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Mullins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorios","family":"Kalaitzidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Lolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souraya","family":"El Sankari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Duprez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"van Pesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0276-383X","authenticated-orcid":false,"given":"Martina","family":"Absinta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ebiom.2023.104701_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104701_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/WCO.0000000000000818","article-title":"Mechanisms underlying progression in multiple sclerosis","volume":"33","author":"Absinta","year":"2020","journal-title":"Curr Opin Neurol"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104701_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-021-00498-5","article-title":"B\u00a0cells in multiple sclerosis \u2014 from targeted depletion to immune reconstitution therapies","volume":"17","author":"Cencioni","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"6578","key":"10.1016\/j.ebiom.2023.104701_bib4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104701_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/14712598.2019.1568407","article-title":"B\u00a0cell depletion in the treatment of multiple sclerosis","volume":"19","author":"Myhr","year":"2019","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104701_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104701_bib7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing\u2013remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104701_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1606468","article-title":"Ocrelizumab versus placebo in primary progressive multiple sclerosis","volume":"376","author":"Montalban","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104701_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40265-021-01650-7","article-title":"Ofatumumab: a review in relapsing forms of multiple sclerosis","volume":"82","author":"Kang","year":"2022","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104701_bib10","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaneurol.2020.1568","article-title":"Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled analysis of 2 randomized clinical trials","volume":"77","author":"Kappos","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ebiom.2023.104701_bib11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","article-title":"A lymphocyte\u2013microglia\u2013astrocyte axis in chronic active multiple sclerosis.","volume":"597","author":"Absinta","year":"2021","journal-title":"Nature"},{"issue":"7745","key":"10.1016\/j.ebiom.2023.104701_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41586-019-0903-2","article-title":"Altered human oligodendrocyte heterogeneity in multiple sclerosis","volume":"566","author":"J\u00e4kel","year":"2019","journal-title":"Nature"},{"issue":"7772","key":"10.1016\/j.ebiom.2023.104701_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41586-019-1404-z","article-title":"Neuronal vulnerability and multilineage diversity in multiple sclerosis","volume":"573","author":"Schirmer","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104701_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00401-016-1636-z","article-title":"Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging","volume":"133","author":"Dal-Bianco","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ebiom.2023.104701_bib15","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamaneurol.2019.2399","article-title":"Association of chronic active multiple sclerosis lesions with disability in vivo","volume":"76","author":"Absinta","year":"2019","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104701_bib16","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/ana.25877","article-title":"Paramagnetic rim lesions are specific to multiple sclerosis: an international multicenter 3T MRI study","volume":"88","author":"Maggi","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebiom.2023.104701_bib17","doi-asserted-by":"crossref","first-page":"awaa436","DOI":"10.1093\/brain\/awaa436","article-title":"Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI","volume":"144","author":"Dal-Bianco","year":"2021","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104701_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41467-019-14118-w","article-title":"Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis","volume":"11","author":"Schafflick","year":"2020","journal-title":"Nat Commun"},{"issue":"13","key":"10.1016\/j.ebiom.2023.104701_bib19","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104701_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.patter.2020.100139","article-title":"scTenifoldNet: a machine learning workflow for constructing and comparing transcriptome-wide gene regulatory networks from single-cell data","volume":"1","author":"Osorio","year":"2020","journal-title":"Patterns"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104701_bib21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(21)00250-7","article-title":"BTK inhibitors as potential therapies for multiple sclerosis","volume":"20","author":"Correale","year":"2021","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104701_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"W1","key":"10.1016\/j.ebiom.2023.104701_bib23","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104701_bib24","article-title":"Gene set knowledge discovery with Enrichr","volume":"1","author":"Xie","year":"2021","journal-title":"Curr Protoc"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104701_bib25","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1177\/1352458517709619","article-title":"Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study","volume":"24","author":"Kappos","year":"2018","journal-title":"Mult Scler J"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104701_bib26","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1177\/1352458514525868","article-title":"Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis","volume":"20","author":"Sati","year":"2014","journal-title":"Mult Scler J"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104701_bib27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ana.23959","article-title":"Seven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process","volume":"74","author":"Absinta","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebiom.2023.104701_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuroimage.2019.02.016","article-title":"Multi-atlas tool for automated segmentation of brain gray matter nuclei and quantification of their magnetic susceptibility","volume":"191","author":"Li","year":"2019","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104701_bib29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/ana.26194","article-title":"7T MRI differentiates remyelinated from demyelinated multiple sclerosis lesions","volume":"90","author":"Kolb","year":"2021","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104701_bib30","doi-asserted-by":"crossref","first-page":"e1138","DOI":"10.1212\/NXI.0000000000001138","article-title":"Dimethyl fumarate reduces inflammation in chronic active multiple sclerosis lesions","volume":"9","author":"Zinger","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"20","key":"10.1016\/j.ebiom.2023.104701_bib31","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1093\/bioinformatics\/btac582","article-title":"propeller: testing for differences in cell type proportions in single cell data","volume":"38","author":"Phipson","year":"2022","journal-title":"Bioinformatics"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104701_bib32","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/brain\/awy151","article-title":"The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells","volume":"141","author":"Machado-Santos","year":"2018","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104701_bib33","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/brain\/awaa117","article-title":"Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions","volume":"143","author":"Fransen","year":"2020","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104701_bib34","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.autrev.2018.03.014","article-title":"Pathogenic role of tissue-resident memory T cells in autoimmune diseases","volume":"17","author":"Wu","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"673","key":"10.1016\/j.ebiom.2023.104701_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adc9778","article-title":"A\u00a0single-cell analysis framework allows for characterization of CSF leukocytes and their tissue of origin in multiple sclerosis","volume":"14","author":"Ostkamp","year":"2022","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104701_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/JCI132727","article-title":"mTOR-dependent translation amplifies microglia priming in aging mice","volume":"131","author":"Keane","year":"2021","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104701_bib37","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1212\/WNL.0000000000012326","article-title":"Chronic white matter inflammation and serum neurofilament levels in multiple sclerosis","volume":"97","author":"Maggi","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104701_bib38","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1038\/s41598-022-08477-6","article-title":"Disease correlates of rim lesions on quantitative susceptibility mapping in multiple sclerosis","volume":"12","author":"Marcille","year":"2022","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104701_bib39","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41582-022-00654-5","article-title":"Slowly expanding lesions are linked to multiple sclerosis progression","volume":"18","author":"Wood","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"17","key":"10.1016\/j.ebiom.2023.104701_bib40","doi-asserted-by":"crossref","first-page":"e1783","DOI":"10.1212\/WNL.0000000000200144","article-title":"Association of slowly expanding lesions on MRI with disability in people with secondary progressive multiple sclerosis","volume":"98","author":"Calvi","year":"2022","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104701_bib41","doi-asserted-by":"crossref","first-page":"e1139","DOI":"10.1212\/NXI.0000000000001139","article-title":"Slowly expanding lesions predict 9-year multiple sclerosis disease progression","volume":"9","author":"Preziosa","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.ebiom.2023.104701_bib42","doi-asserted-by":"crossref","DOI":"10.1177\/13524585221114750","article-title":"Longitudinal clinical study of patients with iron rim lesions in multiple sclerosis","volume":"28","author":"Altokhis","year":"2022","journal-title":"Mult Scler J"},{"key":"10.1016\/j.ebiom.2023.104701_bib43","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.3389\/fimmu.2019.02690","article-title":"Mucosal-associated invariant T cell features and TCR repertoire characteristics during the course of multiple sclerosis","volume":"10","author":"Carnero Contentti","year":"2019","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104701_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/intimm\/dxr047","article-title":"Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis","volume":"23","author":"Miyazaki","year":"2011","journal-title":"Int Immunol"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104701_bib45","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1002\/eji.201344160","article-title":"CD8 + MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis: clinical immunology","volume":"44","author":"Willing","year":"2014","journal-title":"Eur J Immunol"},{"issue":"14","key":"10.1016\/j.ebiom.2023.104701_bib46","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1177\/1352458518814117","article-title":"Slowly expanding\/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions","volume":"25","author":"Elliott","year":"2019","journal-title":"Mult Scler J"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104701_bib47","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1172\/JCI86198","article-title":"Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions","volume":"126","author":"Absinta","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ebiom.2023.104701_bib48","doi-asserted-by":"crossref","first-page":"awab088","DOI":"10.1093\/brain\/awab088","article-title":"Myelin and axon pathology in multiple sclerosis assessed by myelin water and multi-shell diffusion imaging","volume":"144","author":"Rahmanzadeh","year":"2021","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104701_bib49","first-page":"987","article-title":"Quantitative susceptibility mapping of time-dependent susceptibility changes in multiple sclerosis lesions","volume":"40","author":"Zhang","year":"2019","journal-title":"AJNR Am J Neuroradiol"},{"issue":"9","key":"10.1016\/j.ebiom.2023.104701_bib50","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/brain\/awz212","article-title":"Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis","volume":"142","author":"Elliott","year":"2019","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104701_bib51","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1177\/13524585211017020","article-title":"Slowly expanding lesions are a marker of progressive MS \u2013 No","volume":"27","author":"Arnold","year":"2021","journal-title":"Mult Scler J"},{"key":"10.1016\/j.ebiom.2023.104701_bib52","article-title":"Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis","volume":"29","author":"Calvi","year":"2022","journal-title":"Mult Scler J"},{"key":"10.1016\/j.ebiom.2023.104701_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/13524585231162262","article-title":"Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis","volume":"29","author":"Elliott","year":"2023","journal-title":"Mult Scler J"},{"issue":"15 Supplement","key":"10.1016\/j.ebiom.2023.104701_bib54","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1212\/WNL.96.15_supplement.4101","article-title":"MRI characteristics of chronic MS lesions by phase rim detection and\/or slowly expanding properties (4101)","volume":"96","author":"Elliott","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2023.104701_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103340","article-title":"Long-term dynamics of multiple sclerosis iron rim lesions","volume":"57","author":"Weber","year":"2022","journal-title":"Mult Scler Relat Disord"},{"issue":"14","key":"10.1016\/j.ebiom.2023.104701_bib56","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1177\/13524585221106338","article-title":"Impact of disease-modifying therapies on evolving tissue damage in iron rim multiple sclerosis lesions","volume":"28","author":"Eisele","year":"2022","journal-title":"Mult Scler J"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423002669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423002669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:22:48Z","timestamp":1762456968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423002669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":56,"alternative-id":["S2352396423002669"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104701","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B cell depletion therapy does not resolve chronic active multiple sclerosis lesions","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104701"}}